EUVIMEDEUVIMED entdecken
Crossref

Asperosaponin VI ameliorates osteoporosis via skeletal muscle-derived FGF-2-mediated osteoblast differentiation

Jincheng Li, Yanxiang Liang, Xiangjun Li, Li Chen, Chenxi Zhang, Ying Li, Ying Liu, Chun Zhou

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2026.158348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Jincheng Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences; Guangdong Provincial Key Laboratory of Shock and Microcirculation, Southern Medical University, Guangzhou 510515, …. Hauptthemen laut MEDLINE: Saponins, Osteoblasts, Fibroblast Growth Factor 2, Muscle, Skeletal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Guangdong Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Skeletal muscle functions as a dynamic endocrine organ, secreting myokines that contribute to systemic physiological homeostasis. Despite the established osteoprotective effects of Asperosaponin VI (AVI), it remains unknown whether these effects are mediated via the modulation of muscle-derived factors that subsequently regulate bone metabolism. PURPOSE: The present study aims to investigate whether AVI alleviates ovariectomy (OVX)-induced bone loss by modulating muscle-derived signals that exert regulatory effects on osteogenesis. METHODS: Female C57BL/6 OVX mouse models and the co-culture system composed of AVI-treated myotubes and osteoblasts were used. The bone structural microarchitecture, muscle phenotypic changes, bone formation markers were analyzed. Transcriptomics, molecular docking, and cellular thermal shift assays (CETSA) were performed to uncover the core targets and the potential mechanisms involved. RESULTS: AVI significantly improved both trabecular and cortical bone structures in OVX mice, which were associated with simultaneous upregulation of osteogenesis and inhibition of osteoclast activity, along with induction of a phenotypic shift from fast- to slow-twitch muscle fiber types. In vitro studies found that treatment with AVI in myotubes remarkably increased osteogenesis through paracrine action. Mechanistically, AVI bound to and stabilized the transcription factor early growth response 1 (EGR-1) in muscle cells to facilitate rapid EGR-1 nuclear translocation, thus leading to secretion of fibroblast growth factor-2 (FGF-2). Moreover, the key effectors identified in the gene expression profiling, namely fibroblast growth factor receptor 1 (FGFR1), were proven to be required for activation of the osteoblastic Wnt/β-catenin signaling pathway downstream FGF-2. CONCLUSIONS: The present work revealed AVI as an effective therapy in treating post-menopause osteoporosis through direct modulation of EGR-1 in muscle cells to enhance FGF-2 secretion that activated osteoblastic Wnt/β-catenin signaling via FGFR1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SaponinsOsteoblastsFibroblast Growth Factor 2Muscle, SkeletalOsteoporosisAnimalsFemaleMice, Inbred C57BLOvariectomyCell DifferentiationMiceOsteogenesisMuscle Fibers, SkeletalCoculture TechniquesMyokinesWnt Signaling Pathway

Stichwörter der Autor:innen

Asperosaponin VIEGR-1FGF-2MyokineOsteoporosis

Substanzen

SaponinsFibroblast Growth Factor 2akebia saponin DMyokines

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences; Guangdong Provincial Key Laboratory of Shock and Microcirculation, Southern Medical University, Guangzhou 510515, China.
  • School of Pharmacy, Guangzhou Xinhua University, Guangzhou 510520, China.
  • School of Pharmaceutical Sciences; Guangdong Provincial Key Laboratory of Shock and Microcirculation, Southern Medical University, Guangzhou 510515, China. Electronic address: zhouch@smu.edu.cn.

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Guangdong Provincial Natural Science Foundation

Zitieren

APA

Li, J., Liang, Y., Li, X., Chen, L., Zhang, C., Li, Y., Liu, Y., & Zhou, C. (2026). Asperosaponin VI ameliorates osteoporosis via skeletal muscle-derived FGF-2-mediated osteoblast differentiation. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158348

Vancouver

Li J, Liang Y, Li X, Chen L, Zhang C, Li Y, et al. Asperosaponin VI ameliorates osteoporosis via skeletal muscle-derived FGF-2-mediated osteoblast differentiation. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158348

BibTeX
@article{Li2026,
  author = {Li, Jincheng and Liang, Yanxiang and Li, Xiangjun and Chen, Li and Zhang, Chenxi and Li, Ying and Liu, Ying and Zhou, Chun},
  title = {Asperosaponin VI ameliorates osteoporosis via skeletal muscle-derived FGF-2-mediated osteoblast differentiation},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2026.158348}
}
Kostenlos starten →